Biochemical and Biophysical Research Communications, ISSN 0006-291X, 03/2016, Volume 472, Issue 1, pp. 231 - 236
We report characterization of a member of the short-chain dehydrogenase/reductase superfamily encoded in a human gene, . The recombinant protein (DHRS11)...
Dehydroepiandrosterone | Neurosteroid | DHRS11 | 17β-Hydroxysteroid dehydrogenase | Isolithocholic acid | 3β-Hydroxysteroid dehydrogenase | MAMMALIAN REDUCTASES | BIOCHEMISTRY & MOLECULAR BIOLOGY | SHORT-CHAIN DEHYDROGENASE/REDUCTASE | ISOFORM | IDENTIFICATION | 3 beta-Hydroxysteroid dehydrogenase | KETO REDUCTASE FAMILY | NOMENCLATURE | BIOPHYSICS | METABOLISM | PATHWAY | ENZYMES | 17 beta-Hydroxysteroid dehydrogenase | Oxidoreductases - antagonists & inhibitors | Alternative Splicing | Humans | Substrate Specificity | Male | RNA, Messenger - metabolism | Tissue Distribution | Isoenzymes - metabolism | Female | NADP - metabolism | Ketosteroids - chemistry | Recombinant Proteins - metabolism | Oxidoreductases - metabolism | Isoenzymes - genetics | Oxidoreductases - genetics | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | RNA, Messenger - genetics | Enzyme Inhibitors - pharmacology | Enzyme Stability | Recombinant Proteins - genetics | Hot Temperature | 17-Hydroxysteroid Dehydrogenases - genetics | Ketosteroids - metabolism | Kinetics | 17-Hydroxysteroid Dehydrogenases - metabolism | Isoenzymes - antagonists & inhibitors | Hydrogen-Ion Concentration
Dehydroepiandrosterone | Neurosteroid | DHRS11 | 17β-Hydroxysteroid dehydrogenase | Isolithocholic acid | 3β-Hydroxysteroid dehydrogenase | MAMMALIAN REDUCTASES | BIOCHEMISTRY & MOLECULAR BIOLOGY | SHORT-CHAIN DEHYDROGENASE/REDUCTASE | ISOFORM | IDENTIFICATION | 3 beta-Hydroxysteroid dehydrogenase | KETO REDUCTASE FAMILY | NOMENCLATURE | BIOPHYSICS | METABOLISM | PATHWAY | ENZYMES | 17 beta-Hydroxysteroid dehydrogenase | Oxidoreductases - antagonists & inhibitors | Alternative Splicing | Humans | Substrate Specificity | Male | RNA, Messenger - metabolism | Tissue Distribution | Isoenzymes - metabolism | Female | NADP - metabolism | Ketosteroids - chemistry | Recombinant Proteins - metabolism | Oxidoreductases - metabolism | Isoenzymes - genetics | Oxidoreductases - genetics | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | RNA, Messenger - genetics | Enzyme Inhibitors - pharmacology | Enzyme Stability | Recombinant Proteins - genetics | Hot Temperature | 17-Hydroxysteroid Dehydrogenases - genetics | Ketosteroids - metabolism | Kinetics | 17-Hydroxysteroid Dehydrogenases - metabolism | Isoenzymes - antagonists & inhibitors | Hydrogen-Ion Concentration
Journal Article
Journal of Steroid Biochemistry and Molecular Biology, ISSN 0960-0760, 2011, Volume 125, Issue 1, pp. 66 - 82
17β-Hydroxysteroid dehydrogenases (17β-HSDs) are oxidoreductases, which play a key role in estrogen and androgen steroid metabolism by catalyzing final steps...
Animal models | 17β-Hydroxysteroid dehydrogenases | Inhibitors | Protein structures | Therapeutic targets | Humans | Molecular Sequence Data | Male | Isoenzymes - chemistry | Phylogeny | Isoenzymes - classification | 17-Hydroxysteroid Dehydrogenases - classification | Breast Neoplasms - enzymology | Estrogens - chemistry | Isoenzymes - metabolism | Enzyme Inhibitors - chemistry | Female | Molecular Structure | Estrogens - metabolism | Prostatic Neoplasms - drug therapy | Amino Acid Sequence | Catalytic Domain | Enzyme Inhibitors - metabolism | Isoenzymes - genetics | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Models, Molecular | Breast Neoplasms - drug therapy | Sequence Alignment | Animals | Prostatic Neoplasms - enzymology | Androgens - chemistry | Protein Conformation | Androgens - metabolism | 17-Hydroxysteroid Dehydrogenases - chemistry | 17-Hydroxysteroid Dehydrogenases - metabolism
Animal models | 17β-Hydroxysteroid dehydrogenases | Inhibitors | Protein structures | Therapeutic targets | Humans | Molecular Sequence Data | Male | Isoenzymes - chemistry | Phylogeny | Isoenzymes - classification | 17-Hydroxysteroid Dehydrogenases - classification | Breast Neoplasms - enzymology | Estrogens - chemistry | Isoenzymes - metabolism | Enzyme Inhibitors - chemistry | Female | Molecular Structure | Estrogens - metabolism | Prostatic Neoplasms - drug therapy | Amino Acid Sequence | Catalytic Domain | Enzyme Inhibitors - metabolism | Isoenzymes - genetics | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Models, Molecular | Breast Neoplasms - drug therapy | Sequence Alignment | Animals | Prostatic Neoplasms - enzymology | Androgens - chemistry | Protein Conformation | Androgens - metabolism | 17-Hydroxysteroid Dehydrogenases - chemistry | 17-Hydroxysteroid Dehydrogenases - metabolism
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 18, pp. 30552 - 30562
Sex steroid hormones such as estrogens and androgens are involved in the development and differentiation of the breast tissue. The activity and concentration...
Androgens | Breast cancer | Estrogens | HSD17B1 | HSD17B2 | TAMOXIFEN RESPONSE | androgens | estrogens | RECEPTOR EXPRESSION | breast cancer | CELL BIOLOGY | CELL LUNG-CANCER | HUMAN PROSTATE-CANCER | METABOLISM | HYDROXYSTEROID 17-BETA DEHYDROGENASE-1 | COLONIC-CANCER | GENE-EXPRESSION | ESTRADIOL LEVELS | PROGNOSTIC-SIGNIFICANCE | Multigene Family | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Humans | Breast Neoplasms - etiology | Enzyme Inhibitors - pharmacology | Gene Expression Regulation, Neoplastic | Breast Neoplasms - drug therapy | Enzyme Inhibitors - therapeutic use | Breast Neoplasms - metabolism | Animals | Breast Neoplasms - pathology | 17-Hydroxysteroid Dehydrogenases - genetics | Female | Androgens - metabolism | Estrogens - metabolism | 17-Hydroxysteroid Dehydrogenases - metabolism | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Cancer and Oncology | Klinisk medicin | breast cancer; estrogens; androgens; HSD17B1; HSD17B2 | Cancer och onkologi
Androgens | Breast cancer | Estrogens | HSD17B1 | HSD17B2 | TAMOXIFEN RESPONSE | androgens | estrogens | RECEPTOR EXPRESSION | breast cancer | CELL BIOLOGY | CELL LUNG-CANCER | HUMAN PROSTATE-CANCER | METABOLISM | HYDROXYSTEROID 17-BETA DEHYDROGENASE-1 | COLONIC-CANCER | GENE-EXPRESSION | ESTRADIOL LEVELS | PROGNOSTIC-SIGNIFICANCE | Multigene Family | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Humans | Breast Neoplasms - etiology | Enzyme Inhibitors - pharmacology | Gene Expression Regulation, Neoplastic | Breast Neoplasms - drug therapy | Enzyme Inhibitors - therapeutic use | Breast Neoplasms - metabolism | Animals | Breast Neoplasms - pathology | 17-Hydroxysteroid Dehydrogenases - genetics | Female | Androgens - metabolism | Estrogens - metabolism | 17-Hydroxysteroid Dehydrogenases - metabolism | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Cancer and Oncology | Klinisk medicin | breast cancer; estrogens; androgens; HSD17B1; HSD17B2 | Cancer och onkologi
Journal Article
Neurochemistry International, ISSN 0197-0186, 02/2018, Volume 113, pp. 46 - 55
Steroids are reported to have diverse functions in the nervous system. Enzymatic production of steroid hormones has been reported in different cell types,...
Brain | Vitamin D | Neurosteroids | Metabolism | Neurons | Astrocytes | BIOCHEMISTRY & MOLECULAR BIOLOGY | STEROID-METABOLISM | MECHANISMS | NEUROSCIENCES | NEUROPROTECTION | NEUROSTEROID BIOSYNTHESIS | PROGESTERONE SYNTHESIS | ESTROGEN | RAT-BRAIN | CULTURES | Gene Expression Regulation, Enzymologic - drug effects | Steroid 17-alpha-Hydroxylase - antagonists & inhibitors | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Humans | Cells, Cultured | Brain - enzymology | Rats | Vitamin D - pharmacology | Steroids - antagonists & inhibitors | Rats, Sprague-Dawley | Brain - drug effects | 17-Hydroxysteroid Dehydrogenases - biosynthesis | Animals | 17-Hydroxysteroid Dehydrogenases - genetics | Cell Line, Tumor | Steroid 17-alpha-Hydroxylase - genetics | Steroid 17-alpha-Hydroxylase - biosynthesis | Steroids - biosynthesis | Biological Sciences | neurosteroids | vitamin D | Biokemi | Biochemistry | brain | neurons | Naturvetenskap | Biokemi och molekylärbiologi | Biologiska vetenskaper | Biochemistry and Molecular Biology | metabolism | Natural Sciences | astrocytes
Brain | Vitamin D | Neurosteroids | Metabolism | Neurons | Astrocytes | BIOCHEMISTRY & MOLECULAR BIOLOGY | STEROID-METABOLISM | MECHANISMS | NEUROSCIENCES | NEUROPROTECTION | NEUROSTEROID BIOSYNTHESIS | PROGESTERONE SYNTHESIS | ESTROGEN | RAT-BRAIN | CULTURES | Gene Expression Regulation, Enzymologic - drug effects | Steroid 17-alpha-Hydroxylase - antagonists & inhibitors | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Humans | Cells, Cultured | Brain - enzymology | Rats | Vitamin D - pharmacology | Steroids - antagonists & inhibitors | Rats, Sprague-Dawley | Brain - drug effects | 17-Hydroxysteroid Dehydrogenases - biosynthesis | Animals | 17-Hydroxysteroid Dehydrogenases - genetics | Cell Line, Tumor | Steroid 17-alpha-Hydroxylase - genetics | Steroid 17-alpha-Hydroxylase - biosynthesis | Steroids - biosynthesis | Biological Sciences | neurosteroids | vitamin D | Biokemi | Biochemistry | brain | neurons | Naturvetenskap | Biokemi och molekylärbiologi | Biologiska vetenskaper | Biochemistry and Molecular Biology | metabolism | Natural Sciences | astrocytes
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 05/2017, Volume 60, Issue 9, pp. 4086 - 4092
STS and 17β-HSD1 are attractive targets for the treatment of estrogen-dependent diseases like endometriosis and breast cancer. The simultaneous inhibition of...
HUMAN BREAST-CARCINOMA | CANCER PATIENTS | CELLS | CHEMISTRY, MEDICINAL | THERAPY | MCF-7 | IN-VIVO | MICE | ENDOMETRIOSIS | DISCOVERY | SULFOTRANSFERASE | Cell Proliferation | Steryl-Sulfatase - antagonists & inhibitors | Breast Neoplasms - pathology | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Humans | Enzyme Inhibitors - pharmacology | Female | Ligands | Endometriosis - drug therapy | Breast Neoplasms - drug therapy | Enzyme Inhibitors - therapeutic use
HUMAN BREAST-CARCINOMA | CANCER PATIENTS | CELLS | CHEMISTRY, MEDICINAL | THERAPY | MCF-7 | IN-VIVO | MICE | ENDOMETRIOSIS | DISCOVERY | SULFOTRANSFERASE | Cell Proliferation | Steryl-Sulfatase - antagonists & inhibitors | Breast Neoplasms - pathology | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Humans | Enzyme Inhibitors - pharmacology | Female | Ligands | Endometriosis - drug therapy | Breast Neoplasms - drug therapy | Enzyme Inhibitors - therapeutic use
Journal Article
Toxicology Letters, ISSN 0378-4274, 11/2011, Volume 207, Issue 2, pp. 137 - 142
► BPA inhibited 3β-hydroxysteroid dehydrogenase activity. ► BPA inhibited CYP17A1 activity. ► BPA inhibited 17β-hydroxysteroid dehydrogenase 3 activity in...
17β-Hydroxysteroid dehydrogenase 3 | Leydig cells | 3β-Hydroxysteroid dehydrogenase | CYP17A1 | TESTOSTERONE SYNTHESIS | 17 beta-Hydroxysteroid dehydrogenase 3 | REGULATORY STAR PROTEIN | TOXICOLOGY | OCTYLPHENOL | 3 beta-Hydroxysteroid dehydrogenase | DEHYDROGENASE | Steroid 17-alpha-Hydroxylase - antagonists & inhibitors | Testis - metabolism | Benzhydryl Compounds | Leydig Cells - enzymology | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Humans | Rats | Testosterone - biosynthesis | Male | Leydig Cells - drug effects | Rats, Sprague-Dawley | Testis - drug effects | 3-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Animals | Leydig Cells - metabolism | Testis - enzymology | 3-Hydroxysteroid Dehydrogenases - metabolism | Steroid 17-alpha-Hydroxylase - metabolism | 17-Hydroxysteroid Dehydrogenases - metabolism | Phenols - pharmacology | Bisphenol-A | Cytochrome P-450
17β-Hydroxysteroid dehydrogenase 3 | Leydig cells | 3β-Hydroxysteroid dehydrogenase | CYP17A1 | TESTOSTERONE SYNTHESIS | 17 beta-Hydroxysteroid dehydrogenase 3 | REGULATORY STAR PROTEIN | TOXICOLOGY | OCTYLPHENOL | 3 beta-Hydroxysteroid dehydrogenase | DEHYDROGENASE | Steroid 17-alpha-Hydroxylase - antagonists & inhibitors | Testis - metabolism | Benzhydryl Compounds | Leydig Cells - enzymology | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Humans | Rats | Testosterone - biosynthesis | Male | Leydig Cells - drug effects | Rats, Sprague-Dawley | Testis - drug effects | 3-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Animals | Leydig Cells - metabolism | Testis - enzymology | 3-Hydroxysteroid Dehydrogenases - metabolism | Steroid 17-alpha-Hydroxylase - metabolism | 17-Hydroxysteroid Dehydrogenases - metabolism | Phenols - pharmacology | Bisphenol-A | Cytochrome P-450
Journal Article
Journal of Steroid Biochemistry and Molecular Biology, ISSN 0960-0760, 06/2015, Volume 150, pp. 24 - 34
The reductive 17β-hydroxysteroid dehydrogenases which catalyze the last step in estrogen activation for estrogen dependent breast cancer cells were studied....
Reductive 17β-HSDs | Estrogen activation | Cell viability | Breast cancer | Androgen reduction | RNA, Small Interfering - genetics | Cell Proliferation | Signal Transduction | Cell Survival | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Humans | Gene Expression Regulation, Neoplastic | Estrogen Receptor alpha - antagonists & inhibitors | Estradiol Dehydrogenases - antagonists & inhibitors | Feedback, Physiological | Estrogen Receptor alpha - genetics | Cell Cycle | MCF-7 Cells | Estradiol Dehydrogenases - genetics | 17-Hydroxysteroid Dehydrogenases - genetics | Estradiol Dehydrogenases - metabolism | Cell Line, Tumor | Estrogen Receptor alpha - metabolism | 17-Hydroxysteroid Dehydrogenases - metabolism | Estradiol - biosynthesis | Dihydrotestosterone - metabolism | RNA, Small Interfering - metabolism | Estradiol | Oxidoreductases
Reductive 17β-HSDs | Estrogen activation | Cell viability | Breast cancer | Androgen reduction | RNA, Small Interfering - genetics | Cell Proliferation | Signal Transduction | Cell Survival | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Humans | Gene Expression Regulation, Neoplastic | Estrogen Receptor alpha - antagonists & inhibitors | Estradiol Dehydrogenases - antagonists & inhibitors | Feedback, Physiological | Estrogen Receptor alpha - genetics | Cell Cycle | MCF-7 Cells | Estradiol Dehydrogenases - genetics | 17-Hydroxysteroid Dehydrogenases - genetics | Estradiol Dehydrogenases - metabolism | Cell Line, Tumor | Estrogen Receptor alpha - metabolism | 17-Hydroxysteroid Dehydrogenases - metabolism | Estradiol - biosynthesis | Dihydrotestosterone - metabolism | RNA, Small Interfering - metabolism | Estradiol | Oxidoreductases
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 12/2016, Volume 59, Issue 23, pp. 10719 - 10737
17β-HSD14 belongs to the SDR family and oxidizes the hydroxyl group at position 17 of estradiol and 5-androstenediol using NAD+ as cofactor. The goal of this...
LIBRARIES | DEHYDROGENASES | POTENT | CHEMISTRY, MEDICINAL | CATALYZED REACTIONS | BIOLOGICAL EVALUATION | ESTRONE | DERIVATIVES | EXPRESSION | BINDING | DISCOVERY | Dose-Response Relationship, Drug | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Enzyme Inhibitors - chemistry | Humans | Drug Design | Enzyme Inhibitors - pharmacology | Models, Molecular | Crystallography, X-Ray | Molecular Structure | Structure-Activity Relationship | Enzyme Inhibitors - chemical synthesis | 17-Hydroxysteroid Dehydrogenases - metabolism
LIBRARIES | DEHYDROGENASES | POTENT | CHEMISTRY, MEDICINAL | CATALYZED REACTIONS | BIOLOGICAL EVALUATION | ESTRONE | DERIVATIVES | EXPRESSION | BINDING | DISCOVERY | Dose-Response Relationship, Drug | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Enzyme Inhibitors - chemistry | Humans | Drug Design | Enzyme Inhibitors - pharmacology | Models, Molecular | Crystallography, X-Ray | Molecular Structure | Structure-Activity Relationship | Enzyme Inhibitors - chemical synthesis | 17-Hydroxysteroid Dehydrogenases - metabolism
Journal Article
Cancer Letters, ISSN 0304-3835, 2017, Volume 393, pp. 16 - 21
Abstract Drug reprofiling is emerging as an effective paradigm for discovery of cancer treatments. Herein, an antipsychotic drug is immobilised using the Magic...
Hematology, Oncology and Palliative Medicine | Adenocarcinoma | Chemical genomics | Drug reprofiling | 17-β-Hydroxysteroid dehydrogenase 10 | Drosophila melanogaster | THERAPEUTICS | CELLS | 17-beta-Hydroxysteroid dehydrogenase 10 | ALZHEIMERS-DISEASE | GLIDE | IDENTIFICATION | CANCER | DROSOPHILA | DISCOVERY | ONCOLOGY | ACCURATE DOCKING | INHIBITOR | Humans | 3-Hydroxyacyl CoA Dehydrogenases - metabolism | Male | Structure-Activity Relationship | 3-Hydroxyacyl CoA Dehydrogenases - genetics | Molecular Targeted Therapy | Drosophila melanogaster - genetics | Dose-Response Relationship, Drug | Prostatic Neoplasms - genetics | Time Factors | Enzyme Inhibitors - chemistry | Drug Compounding | Adenocarcinoma - genetics | Antineoplastic Agents - pharmacology | 3-Hydroxyacyl CoA Dehydrogenases - chemistry | Genomics - methods | Prostatic Neoplasms - drug therapy | Bacteriophage T7 - genetics | 3-Hydroxyacyl CoA Dehydrogenases - antagonists & inhibitors | Gene Library | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Adenocarcinoma - enzymology | Enzyme Inhibitors - pharmacology | Risperidone - pharmacology | Risperidone - chemistry | Antineoplastic Agents - chemistry | Adenocarcinoma - drug therapy | Drosophila melanogaster - drug effects | Xenograft Model Antitumor Assays | Animals | Antipsychotic Agents - chemistry | Tumor Burden - drug effects | Mice, Nude | 17-Hydroxysteroid Dehydrogenases - genetics | Drug Repositioning - methods | Cell Line, Tumor | Drosophila melanogaster - enzymology | Linoleic Acids, Conjugated - chemistry | Prostatic Neoplasms - enzymology | Protein Conformation | Cell Proliferation - drug effects | Molecular Docking Simulation | Antipsychotic Agents - pharmacology | 17-Hydroxysteroid Dehydrogenases - chemistry | 17-Hydroxysteroid Dehydrogenases - metabolism | Enzymes | Antipsychotic drugs | Analysis | Genomics | Genetic research | Genetic aspects | Drug therapy | Prostate cancer | Cancer | Drugs | Medical colleges | Fruit-flies | Drug discovery | Polypeptides | Multiple myeloma | Oncology | Breast cancer | Genomes | Experiments | Fatty acids | Cancer therapies | Psychotropic drugs | Organic chemicals | Enzyme kinetics | Drug dosages
Hematology, Oncology and Palliative Medicine | Adenocarcinoma | Chemical genomics | Drug reprofiling | 17-β-Hydroxysteroid dehydrogenase 10 | Drosophila melanogaster | THERAPEUTICS | CELLS | 17-beta-Hydroxysteroid dehydrogenase 10 | ALZHEIMERS-DISEASE | GLIDE | IDENTIFICATION | CANCER | DROSOPHILA | DISCOVERY | ONCOLOGY | ACCURATE DOCKING | INHIBITOR | Humans | 3-Hydroxyacyl CoA Dehydrogenases - metabolism | Male | Structure-Activity Relationship | 3-Hydroxyacyl CoA Dehydrogenases - genetics | Molecular Targeted Therapy | Drosophila melanogaster - genetics | Dose-Response Relationship, Drug | Prostatic Neoplasms - genetics | Time Factors | Enzyme Inhibitors - chemistry | Drug Compounding | Adenocarcinoma - genetics | Antineoplastic Agents - pharmacology | 3-Hydroxyacyl CoA Dehydrogenases - chemistry | Genomics - methods | Prostatic Neoplasms - drug therapy | Bacteriophage T7 - genetics | 3-Hydroxyacyl CoA Dehydrogenases - antagonists & inhibitors | Gene Library | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Adenocarcinoma - enzymology | Enzyme Inhibitors - pharmacology | Risperidone - pharmacology | Risperidone - chemistry | Antineoplastic Agents - chemistry | Adenocarcinoma - drug therapy | Drosophila melanogaster - drug effects | Xenograft Model Antitumor Assays | Animals | Antipsychotic Agents - chemistry | Tumor Burden - drug effects | Mice, Nude | 17-Hydroxysteroid Dehydrogenases - genetics | Drug Repositioning - methods | Cell Line, Tumor | Drosophila melanogaster - enzymology | Linoleic Acids, Conjugated - chemistry | Prostatic Neoplasms - enzymology | Protein Conformation | Cell Proliferation - drug effects | Molecular Docking Simulation | Antipsychotic Agents - pharmacology | 17-Hydroxysteroid Dehydrogenases - chemistry | 17-Hydroxysteroid Dehydrogenases - metabolism | Enzymes | Antipsychotic drugs | Analysis | Genomics | Genetic research | Genetic aspects | Drug therapy | Prostate cancer | Cancer | Drugs | Medical colleges | Fruit-flies | Drug discovery | Polypeptides | Multiple myeloma | Oncology | Breast cancer | Genomes | Experiments | Fatty acids | Cancer therapies | Psychotropic drugs | Organic chemicals | Enzyme kinetics | Drug dosages
Journal Article
Journal of Steroid Biochemistry and Molecular Biology, ISSN 0960-0760, 2011, Volume 125, Issue 1, pp. 148 - 161
17β-Hydroxysteroid dehydrogenase type 3 and 5 (17β-HSD3 and 17β-HSD5) catalyze testosterone biosynthesis and thereby constitute therapeutic targets for...
Steroid-dependent disease | Pharmacophore screening | Androgens | Inhibitor development | Estrogens | KETO REDUCTASE AKR1C3 | IN-SILICO PHARMACOLOGY | BIOCHEMISTRY & MOLECULAR BIOLOGY | 20-ALPHA-HYDROXYSTEROID DEHYDROGENASE | CRYSTAL-STRUCTURES | 11-BETA-HYDROXYSTEROID DEHYDROGENASES | 4-HYDROXYPHENYL KETONES | DISCOVERY | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | ENDOCRINOLOGY & METABOLISM | PROSTAGLANDIN-F-SYNTHASE | BIOCHEMICAL EVALUATION | Enzyme Inhibitors - metabolism | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Humans | Crystallography, X-Ray | Drug Discovery | Hydroxyprostaglandin Dehydrogenases - metabolism | Hydroxyprostaglandin Dehydrogenases - genetics | 3-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Hydroxyprostaglandin Dehydrogenases - antagonists & inhibitors | Aldo-Keto Reductase Family 1 Member C3 | 17-Hydroxysteroid Dehydrogenases - genetics | Enzyme Inhibitors - chemistry | HEK293 Cells | 3-Hydroxysteroid Dehydrogenases - metabolism | Ligands | 3-Hydroxysteroid Dehydrogenases - chemistry | Molecular Structure | 3-Hydroxysteroid Dehydrogenases - genetics | Hydroxyprostaglandin Dehydrogenases - chemistry | 17-Hydroxysteroid Dehydrogenases - chemistry | 17-Hydroxysteroid Dehydrogenases - metabolism | Databases, Factual
Steroid-dependent disease | Pharmacophore screening | Androgens | Inhibitor development | Estrogens | KETO REDUCTASE AKR1C3 | IN-SILICO PHARMACOLOGY | BIOCHEMISTRY & MOLECULAR BIOLOGY | 20-ALPHA-HYDROXYSTEROID DEHYDROGENASE | CRYSTAL-STRUCTURES | 11-BETA-HYDROXYSTEROID DEHYDROGENASES | 4-HYDROXYPHENYL KETONES | DISCOVERY | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | ENDOCRINOLOGY & METABOLISM | PROSTAGLANDIN-F-SYNTHASE | BIOCHEMICAL EVALUATION | Enzyme Inhibitors - metabolism | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Humans | Crystallography, X-Ray | Drug Discovery | Hydroxyprostaglandin Dehydrogenases - metabolism | Hydroxyprostaglandin Dehydrogenases - genetics | 3-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Hydroxyprostaglandin Dehydrogenases - antagonists & inhibitors | Aldo-Keto Reductase Family 1 Member C3 | 17-Hydroxysteroid Dehydrogenases - genetics | Enzyme Inhibitors - chemistry | HEK293 Cells | 3-Hydroxysteroid Dehydrogenases - metabolism | Ligands | 3-Hydroxysteroid Dehydrogenases - chemistry | Molecular Structure | 3-Hydroxysteroid Dehydrogenases - genetics | Hydroxyprostaglandin Dehydrogenases - chemistry | 17-Hydroxysteroid Dehydrogenases - chemistry | 17-Hydroxysteroid Dehydrogenases - metabolism | Databases, Factual
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 01/2014, Volume 57, Issue 1, pp. 204 - 222
17β-Hydroxysteroid dehydrogenase type 1 (17β-HSD1) is thought to play a pivotal role in the progression of estrogen-sensitive breast cancer by transforming...
BREAST-CANCER | C-16 DERIVATIVES | DEHYDROGENASES | MAINTENANCE | CHEMISTRY, MEDICINAL | THERAPY | SODIUM-IODIDE SYMPORTER | ESTRADIOL DERIVATIVES | ESTRONE | AROMATASE | CARCINOMA | Estradiol - analogs & derivatives | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Humans | Enzyme Inhibitors - pharmacology | HEK293 Cells | Models, Molecular | Cell Proliferation - drug effects | Structure-Activity Relationship | Enzyme Inhibitors - chemical synthesis | Drug Discovery
BREAST-CANCER | C-16 DERIVATIVES | DEHYDROGENASES | MAINTENANCE | CHEMISTRY, MEDICINAL | THERAPY | SODIUM-IODIDE SYMPORTER | ESTRADIOL DERIVATIVES | ESTRONE | AROMATASE | CARCINOMA | Estradiol - analogs & derivatives | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Humans | Enzyme Inhibitors - pharmacology | HEK293 Cells | Models, Molecular | Cell Proliferation - drug effects | Structure-Activity Relationship | Enzyme Inhibitors - chemical synthesis | Drug Discovery
Journal Article
Journal of Steroid Biochemistry and Molecular Biology, ISSN 0960-0760, 09/2017, Volume 172, pp. 36 - 45
This study addresses first the role of human 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) in breast cancer (BC) cells. The enzyme has a high...
Enzyme substrate inhibition | Reductive 17β-hydroxysteroid dehydrogenases | Breast cancer | Estradiol regulation of 17β-hydroxysteroid dehydrogenase type 7 | Enzymology | Reductive | CANCER CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | HUMAN ESTROGENIC 17-BETA-HYDROXYSTEROID-DEHYDROGENASE | 17 beta-hydroxysteroid dehydrogenases | PROLIFERATION | ESTRONE REDUCTION | Estradiol regulation of 17 beta-hydroxysteroid dehydrogenase type 7 | 3-DIMENSIONAL STRUCTURE | ENZYME | STEROID DEHYDROGENASE | ESTRADIOL | ENDOCRINOLOGY & METABOLISM | TYPE-1 17-BETA-HYDROXYSTEROID-DEHYDROGENASE | HUMAN-BREAST-CARCINOMA | RNA, Small Interfering - genetics | Epithelial Cells - metabolism | Epithelial Cells - drug effects | Humans | Substrate Specificity | 17-Hydroxysteroid Dehydrogenases - isolation & purification | MCF-7 Cells | Dihydrotestosterone - pharmacology | Female | Placenta - chemistry | Epithelial Cells - cytology | Binding Sites | Estradiol - pharmacology | Dihydrotestosterone - metabolism | Estradiol - metabolism | Gene Expression | Protein Structure, Secondary | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Models, Molecular | Pregnancy | Feedback, Physiological | 17-Hydroxysteroid Dehydrogenases - genetics | Cell Line, Tumor | Protein Binding | Kinetics | 17-Hydroxysteroid Dehydrogenases - metabolism | RNA, Small Interfering - metabolism
Enzyme substrate inhibition | Reductive 17β-hydroxysteroid dehydrogenases | Breast cancer | Estradiol regulation of 17β-hydroxysteroid dehydrogenase type 7 | Enzymology | Reductive | CANCER CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | HUMAN ESTROGENIC 17-BETA-HYDROXYSTEROID-DEHYDROGENASE | 17 beta-hydroxysteroid dehydrogenases | PROLIFERATION | ESTRONE REDUCTION | Estradiol regulation of 17 beta-hydroxysteroid dehydrogenase type 7 | 3-DIMENSIONAL STRUCTURE | ENZYME | STEROID DEHYDROGENASE | ESTRADIOL | ENDOCRINOLOGY & METABOLISM | TYPE-1 17-BETA-HYDROXYSTEROID-DEHYDROGENASE | HUMAN-BREAST-CARCINOMA | RNA, Small Interfering - genetics | Epithelial Cells - metabolism | Epithelial Cells - drug effects | Humans | Substrate Specificity | 17-Hydroxysteroid Dehydrogenases - isolation & purification | MCF-7 Cells | Dihydrotestosterone - pharmacology | Female | Placenta - chemistry | Epithelial Cells - cytology | Binding Sites | Estradiol - pharmacology | Dihydrotestosterone - metabolism | Estradiol - metabolism | Gene Expression | Protein Structure, Secondary | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Models, Molecular | Pregnancy | Feedback, Physiological | 17-Hydroxysteroid Dehydrogenases - genetics | Cell Line, Tumor | Protein Binding | Kinetics | 17-Hydroxysteroid Dehydrogenases - metabolism | RNA, Small Interfering - metabolism
Journal Article
Journal of Steroid Biochemistry and Molecular Biology, ISSN 0960-0760, 07/2017, Volume 171, pp. 80 - 93
Phytoestrogens are plant-derived compounds that functionally and structurally mimic mammalian estrogens. Phytoestrogens have broad inhibitory activities toward...
Hydroxysteroid dehydrogenases | Phytoestrogens | Flavonoids | Structure–activity relationships | Structural biology | Enzyme inhibition kinetics | COENZYME | CONSTANTS | BIOCHEMISTRY & MOLECULAR BIOLOGY | CRYSTALLOGRAPHY | Structure-activity relationships | COCHLIOBOLUS-LUNATUS | GENISTEIN | SUBSTRATE-SPECIFICITY | ENDOCRINOLOGY & METABOLISM | TYPE-1 | INSIGHTS | Fungal Proteins - chemistry | Molecular Conformation | Phytoestrogens - chemistry | Crystallography, X-Ray | Holoenzymes - chemistry | Fungal Proteins - antagonists & inhibitors | Structure-Activity Relationship | Holoenzymes - metabolism | Genistein - metabolism | Databases, Protein | Enzyme Inhibitors - chemistry | Kaempferols - metabolism | Binding Sites | Recombinant Proteins - metabolism | Biocatalysis | Enzyme Inhibitors - metabolism | Hydroxylation | Kaempferols - chemistry | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Models, Molecular | Recombinant Proteins - chemistry | Genistein - chemistry | Ascomycota - enzymology | Fungal Proteins - genetics | 17-Hydroxysteroid Dehydrogenases - genetics | Flavonoids - metabolism | Phytoestrogens - metabolism | Protein Conformation | Holoenzymes - genetics | 17-Hydroxysteroid Dehydrogenases - chemistry | 17-Hydroxysteroid Dehydrogenases - metabolism | Dietary Supplements | Flavonoids - chemistry | Fungal Proteins - metabolism
Hydroxysteroid dehydrogenases | Phytoestrogens | Flavonoids | Structure–activity relationships | Structural biology | Enzyme inhibition kinetics | COENZYME | CONSTANTS | BIOCHEMISTRY & MOLECULAR BIOLOGY | CRYSTALLOGRAPHY | Structure-activity relationships | COCHLIOBOLUS-LUNATUS | GENISTEIN | SUBSTRATE-SPECIFICITY | ENDOCRINOLOGY & METABOLISM | TYPE-1 | INSIGHTS | Fungal Proteins - chemistry | Molecular Conformation | Phytoestrogens - chemistry | Crystallography, X-Ray | Holoenzymes - chemistry | Fungal Proteins - antagonists & inhibitors | Structure-Activity Relationship | Holoenzymes - metabolism | Genistein - metabolism | Databases, Protein | Enzyme Inhibitors - chemistry | Kaempferols - metabolism | Binding Sites | Recombinant Proteins - metabolism | Biocatalysis | Enzyme Inhibitors - metabolism | Hydroxylation | Kaempferols - chemistry | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Models, Molecular | Recombinant Proteins - chemistry | Genistein - chemistry | Ascomycota - enzymology | Fungal Proteins - genetics | 17-Hydroxysteroid Dehydrogenases - genetics | Flavonoids - metabolism | Phytoestrogens - metabolism | Protein Conformation | Holoenzymes - genetics | 17-Hydroxysteroid Dehydrogenases - chemistry | 17-Hydroxysteroid Dehydrogenases - metabolism | Dietary Supplements | Flavonoids - chemistry | Fungal Proteins - metabolism
Journal Article
Journal of Cellular Biochemistry, ISSN 0730-2312, 04/2016, Volume 117, Issue 4, pp. 904 - 916
ABSTRACT Bacterial lipopolysaccharide (LPS) is the most important contributing factor in pathogenesis of bacterial infection in male accessory glands; and it...
LEYDIG CELLS | SIRT4 | STEROIDOGENESIS | APOPTOSIS | LPS | SIGNALING PATHWAYS | OXIDATIVE STRESS | PROTEIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | MITOCHONDRIA | RECEPTOR | SUPPRESSION | CELL BIOLOGY | EXPRESSION | Leydig Cells - cytology | Apoptosis - drug effects | Glutathione - metabolism | JNK Mitogen-Activated Protein Kinases - metabolism | Male | Leydig Cells - drug effects | Lipopolysaccharides - antagonists & inhibitors | Stilbenes - pharmacology | Membrane Potential, Mitochondrial - drug effects | RNA, Messenger - metabolism | 3-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Glutathione - agonists | Leydig Cells - metabolism | 3-Hydroxysteroid Dehydrogenases - metabolism | JNK Mitogen-Activated Protein Kinases - genetics | Sirtuins - genetics | Cell Line | Cell Survival - drug effects | Signal Transduction | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | RNA, Messenger - genetics | Gene Expression Regulation | Rats | Glutathione - antagonists & inhibitors | Antioxidants - pharmacology | Mitochondria - drug effects | Animals | 17-Hydroxysteroid Dehydrogenases - genetics | Lipopolysaccharides - pharmacology | 3-Hydroxysteroid Dehydrogenases - genetics | 17-Hydroxysteroid Dehydrogenases - metabolism | Sirtuins - metabolism | Bacterial infections | RNA | Mitogens | Resveratrol
LEYDIG CELLS | SIRT4 | STEROIDOGENESIS | APOPTOSIS | LPS | SIGNALING PATHWAYS | OXIDATIVE STRESS | PROTEIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | MITOCHONDRIA | RECEPTOR | SUPPRESSION | CELL BIOLOGY | EXPRESSION | Leydig Cells - cytology | Apoptosis - drug effects | Glutathione - metabolism | JNK Mitogen-Activated Protein Kinases - metabolism | Male | Leydig Cells - drug effects | Lipopolysaccharides - antagonists & inhibitors | Stilbenes - pharmacology | Membrane Potential, Mitochondrial - drug effects | RNA, Messenger - metabolism | 3-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Glutathione - agonists | Leydig Cells - metabolism | 3-Hydroxysteroid Dehydrogenases - metabolism | JNK Mitogen-Activated Protein Kinases - genetics | Sirtuins - genetics | Cell Line | Cell Survival - drug effects | Signal Transduction | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | RNA, Messenger - genetics | Gene Expression Regulation | Rats | Glutathione - antagonists & inhibitors | Antioxidants - pharmacology | Mitochondria - drug effects | Animals | 17-Hydroxysteroid Dehydrogenases - genetics | Lipopolysaccharides - pharmacology | 3-Hydroxysteroid Dehydrogenases - genetics | 17-Hydroxysteroid Dehydrogenases - metabolism | Sirtuins - metabolism | Bacterial infections | RNA | Mitogens | Resveratrol
Journal Article